Since its establishment in 2001, Marksans Pharma has grown exponentially, encompassing phases of transformation, consolidation, as well as mergers and acquisitions. Originating as a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., the company has progressively strengthened its position, establishing a notable presence in the global pharmaceutical arena.
Acquired a manufacturing facility from Tevapharm India. 2023
Acquired Access Healthcare Dubai 2022
Acquired Time Cap Laboratories Inc. USA 2015
Marksans Pharma established itself as a global player 2008
- Acquired Bells, Sons & Co. (Druggists) Ltd.
- Acquired Relonchem Limited
Acquired Nova Pharmaceuticals Australasia Pty Ltd. 2005
- Spun off into a separate entity - Glenmark Laboratories Ltd.
- Changed its name to "Marksans Pharma Ltd"
Marksans was incorporated as a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd. 2001